[1]
YENİAY, L. et al. 2012. Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors. Turkish Journal of Gastroenterology. 23, 6 (Jan. 2012), 736–740. DOI:https://doi.org/10.4318/tjg.2012.0476.